NasdaqGS - Delayed Quote USD
Pyxis Oncology, Inc. (PYXS)
1.3400
-0.0100
(-0.74%)
At close: June 10 at 4:00:01 PM EDT
1.3800
+0.04
+(2.99%)
After hours: June 10 at 7:47:16 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 13.91M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CONNEALY PAMELA ANN Chief Operating Officer | Purchase at price 1.96 - 2.00 per share. | Indirect | 174,364 | Nov 26, 2024 |
| PALANI SANTHOSH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| FLAVIN JOHN L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| LEWIS-HALL FREDA C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| HUMPHREY RACHEL W M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| DUPONT JAKOB Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| CLINE DARREN S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| WADHANE JITENDRA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| CONNEALY PAMELA ANN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2024 |
| WADHANE JITENDRA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2023 |
| CONNEALY PAMELA ANN Chief Operating Officer | Purchase at price 1.87 per share. | Direct | 14,960 | Sep 28, 2023 |
| WADHANE JITENDRA Officer | Purchase at price 1.87 per share. | Direct | 4,675 | Sep 27, 2023 |
| CONNEALY PAMELA ANN Chief Operating Officer | Purchase at price 1.85 per share. | Direct | 11,868 | Sep 27, 2023 |
| WADHANE JITENDRA Officer | Purchase at price 1.77 per share. | Direct | 8,850 | Sep 25, 2023 |
| CONNEALY PAMELA ANN Chief Operating Officer | Purchase at price 1.67 per share. | Direct | 20,044 | Sep 25, 2023 |
| WADHANE JITENDRA Officer | Purchase at price 1.74 per share. | Direct | 4,349 | Sep 22, 2023 |
| CONNEALY PAMELA ANN Chief Operating Officer | Purchase at price 1.74 per share. | Direct | 8,695 | Sep 22, 2023 |
| SULLIVAN LARA S. M.D. Chief Executive Officer | Sale at price 2.10 - 2.25 per share. | Direct | 18,161 | Sep 18, 2023 |
| SULLIVAN LARA S. M.D. Chief Executive Officer | Sale at price 2.25 - 2.27 per share. | Direct | 63,301 | Sep 13, 2023 |
| SULLIVAN LARA S. M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 7, 2023 |
| WADHANE JITENDRA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 7, 2023 |
| CONNEALY PAMELA ANN Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 7, 2023 |
Related Tickers
TCRX TScan Therapeutics, Inc.
1.6900
-4.52%
ACRV Acrivon Therapeutics, Inc.
1.2800
0.00%
ARTV Artiva Biotherapeutics, Inc.
2.0800
-1.42%
BCAX Bicara Therapeutics Inc.
12.58
+9.58%
HOWL Werewolf Therapeutics, Inc.
1.3300
-5.67%
VOR Vor Biopharma Inc.
0.2295
+2.96%
ALEC Alector, Inc.
1.5900
+10.42%
ALXO ALX Oncology Holdings Inc.
0.5338
-7.76%
ITOS iTeos Therapeutics, Inc.
10.03
-0.10%
CLYM Climb Bio, Inc.
1.3700
+2.24%